Vectoroncology.com Website Review

transforming healthcare with next generation real world data and ai. concerto healthai is honored to be presenting at the 37th annual j.p. morgan health conference, january 8 2019 in san francisco. our mission is to improve patient outcomes and accelerate needed new innovations by building a system of definitive real world data, advanced ai insights, leading outcomes & data science talent, within a leading clinical cloud solution. we believe in cancerlinq’s mission – because when today’s trial data informs our decisions, we tap into only 3% of the cancer patient population. cancerlinq™ lets you learn from the other 97%. we’re proud to be a long term, exclusive partner to cancerlinq to make that concerto healthai is the leader in clinical outcomes an*lytics, clinical data abstraction services, and pro technologies and services. eurekahealth platform is the most advanced ai-enabled technology platform for understanding real world data, supercharged with unique proprietary ai models and ai apis. this purpose-built ai platform leverages a suite of machine learning, natural language processing, and other ai techniques in a cloud-delivered solution built for our real-world data and our customers’ – from all sources, rct, rwd,. meet the new model for clinical development and outcomes research. backed by symphonyai, dr. romesh wadhwani’s $1 billion fund.. we’re proud to be backed by symphonyai, the leading $1 billion private group of b2b ai solutions companies for healthcare and other. key sectors.  symphonyai group is 1,500 employees strong, including top talent in data sciences and ai in each vertical. we’ve been growing 80% yoy, we’re financially strong, and we’re excited to be on a journey to transform healthcare through data and ai meet our team of business executives and serial entrepreneurs in oncology tech solutions. prospective and retrospective clinical studies are becoming real world. the time has come to improve cancer care, accelerate the generation of evidence in support of new thera*eutic approaches, and use next